The a7 protein is ready for its close-up

Researchers have identified the structure of a key member of a family of proteins called nicotinic acetylcholine receptors in three different shapes. The work could eventually lead to new pharmaceutical treatments for a large range of diseases or infections including schizophrenia, lung cancer, and even COVID-19.